Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification.

Published in: Breast cancer (Tokyo, Japan) (2023)

Our findings provided a novel and effective model for predicting BRCA prognosis and the propensity to different treatment modalities, thus contributing to the optimization of personalized BRCA therapy in the future.

Keyphrases

breast cancer risk
current status
mesenchymal stem cells
bone marrow
network analysis
high density